Carbapenems were commonly prescribed as targeted therapy for extended-spectrum cephalosporin-resistant Enterobacterales infections despite significant changes in updated guidance, data show.

Also making the WHO's critical list are two types of Enterobacterales bacteria: those resistant to cephalosporins and those resistant to carbapenems. Enterobacterales is an order of bacteria ...

Thus, cefepime–taniborbactam was shown to be a potential treatment option for patients with complicated UTI and acute pyelonephritis caused by Enterobacterales species and P. aeruginosa ...

Tebipenem pivoxil hydrobromide is an orally bioavailable carbapenem with activity against uropathogenic Enterobacterales, including extended-spectrum beta-lactamase–producing and fluoroquinolone ...

Opens in a new tab or window Broad spectrum carbapenems were the most commonly used therapy for targeted treatment of extended-spectrum cephalosporin-resistant (ECR) Enterobacterales infections in ...

improves 30-day clinical outcomes in patients hospitalized with Enterobacterales bacteremia. “Starting early PDAT may be important not only for antimicrobial stewardship but also for improving ...

In 2012 to 2015, 10 percent of carbapenem-resistant Enterobacterales (CRE) cases in the United States were community-associated (CA), according to a study published online July 27 in the American ...

In a recent study published in the American Journal of Infection Control, researchers assessed carbapenem-resistant Enterobacterales (CRE) epidemiology across eight United States (US) metropolitan ...